These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

164 related items for PubMed ID: 11955393

  • 1. [Single instillation of epirubicin for the prophylaxis of recurrent primary superficial bladder carcinoma].
    Liu B, Zhang Y, Wang Z, Ding Q, Chen B, Wang J, Jiang H.
    Zhonghua Wai Ke Za Zhi; 2002 Feb; 40(2):112-5. PubMed ID: 11955393
    [Abstract] [Full Text] [Related]

  • 2. Randomized study of single instillation of epirubicin for superficial bladder carcinoma: long-term clinical outcomes.
    Liu B, Wang Z, Chen B, Yu J, Zhang P, Ding Q, Zhang Y.
    Cancer Invest; 2006 Mar; 24(2):160-3. PubMed ID: 16537185
    [Abstract] [Full Text] [Related]

  • 3. [Efficacy and safety of different dosages of intravesical epirubicin instillation for prevention of primary superficial bladder carcinoma from recurrence].
    Wu ZB, Lin GB, Chen BJ, Wu ZM, Rong RM.
    Zhonghua Zhong Liu Za Zhi; 2005 Aug; 27(8):507-9. PubMed ID: 16188156
    [Abstract] [Full Text] [Related]

  • 4. Early and large-dose intravesical instillation of epirubicin to prevent superficial bladder carcinoma recurrence after transurethral resection.
    Mitsumori K, Tsuchiya N, Habuchi T, Li Z, Akao T, Ohyama C, Sato K, Kato T.
    BJU Int; 2004 Aug; 94(3):317-21. PubMed ID: 15291859
    [Abstract] [Full Text] [Related]

  • 5. [Effect of prophylactic treatment with intravesical epirubicin in recurrence of superficial bladder tumor].
    Pérez Mestre M, Cuñat Albert E, Francisco Mingol V, Arrufat Boix JM, Gallego Gómez J.
    Arch Esp Urol; 1999 May; 52(4):345-50. PubMed ID: 10380324
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. [Continuous intravesical instillation of epirubicin immediately after transurethral resection of superficial bladder cancer: a prospective controlled study].
    Maekawa S, Suzuki H, Ohkubo K, Aoki Y, Okada T, Maeda H, Ogura K, Arai Y.
    Hinyokika Kiyo; 2000 May; 46(5):301-6. PubMed ID: 10876750
    [Abstract] [Full Text] [Related]

  • 12. [Intravesical instillation with epirubicin as a prophylactic treatment for superficial bladder cancer--using two different schedules].
    Segawa N, Nishida T, Takahara K, Nomi H, Azuma H, Katsuoka Y.
    Hinyokika Kiyo; 2008 Nov; 54(11):711-6. PubMed ID: 19068724
    [Abstract] [Full Text] [Related]

  • 13. [Clinical research on prevention of recurrence of superficial bladder cancer--comparative study on clinical efficacy of bleomycin intravesical instillation and bestatin].
    Kumamoto Y, Tsukamoto T, Tamiya T, Takatsuka K, Furuya S, Yokoyama E, Honma A, Aoyama T, Tanda H, Kato S.
    Hinyokika Kiyo; 1985 Oct; 31(10):1861-83. PubMed ID: 2418659
    [Abstract] [Full Text] [Related]

  • 14. Intravesical chemotherapy for maximum prophylaxis of new early phase superficial bladder carcinoma treated by transurethral resection: a combined analysis of trials by the Japanese Urological Cancer Research Group using smoothed hazard function.
    Hinotsu S, Akaza H, Ohashi Y, Kotake T.
    Cancer; 1999 Nov 01; 86(9):1818-26. PubMed ID: 10547556
    [Abstract] [Full Text] [Related]

  • 15. Should all patients with non-muscle-invasive bladder cancer receive early intravesical chemotherapy after transurethral resection? The results of a prospective randomised multicentre study.
    Gudjónsson S, Adell L, Merdasa F, Olsson R, Larsson B, Davidsson T, Richthoff J, Hagberg G, Grabe M, Bendahl PO, Månsson W, Liedberg F.
    Eur Urol; 2009 Apr 01; 55(4):773-80. PubMed ID: 19153001
    [Abstract] [Full Text] [Related]

  • 16. Bacillus Calmette-Guerin versus epirubicin for primary, secondary or concurrent carcinoma in situ of the bladder: results of a European Organization for the Research and Treatment of Cancer--Genito-Urinary Group Phase III Trial (30906).
    de Reijke TM, Kurth KH, Sylvester RJ, Hall RR, Brausi M, van de Beek K, Landsoght KE, Carpentier P, European Organization for the Research and Treatment of Cancer-Genito-Urinary Group.
    J Urol; 2005 Feb 01; 173(2):405-9. PubMed ID: 15643181
    [Abstract] [Full Text] [Related]

  • 17. [Intravesical instillation of doxorubicin or epirubicin for chemoprophylaxis of superficial bladder cancer--the fifth study of the Japanese Urological Cancer Research Group for Adriamycin/Farumorubicin].
    Hinotsu S, Akaza H, Isaka S, Kagawa S, Koiso K, Kotake T, Machida T, Matsumura Y, Niijima T, Obata K, Ohashi Y, Ohe H, Shimazaki J, Tashiro K, Japanese Urological Cancer Research Group for Adriamycin/Farumorubicin.
    Gan To Kagaku Ryoho; 2002 Jan 01; 29(1):73-80. PubMed ID: 11816482
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. [Intravesical instillation of epirubicin hydrochloride in superficial bladder tumor--prophylactic and therapeutic instillation for carcinoma in situ].
    Shichiri Y, Kanba T, Yoshida S, Arai Y.
    Hinyokika Kiyo; 1995 May 01; 41(5):359-64. PubMed ID: 7598036
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.